When US firm Moderna’s 94.5% effective Covid vaccine will be available in UK

The race to find an effective vaccine against coronavirus is heating up, with a US firm revealing its impressive results from phase three trials of its jab.

The news coming from US company Moderna has been deemed “tremendously exciting”, and comes hot on the heels of a similar results from Pfizer.

The promising trial data shows that Moderna’s jab is more than 94.5% effective in preventing coronavirus.

Moderna’s CEO Stephane Bancel called a the findings a “game changer.”

Among the trial’s 30,000 participants, there were observed 95 confirmed Covid-19 infections.

Modern said 90 of these were observed in the placebo group, while five cases were found in those who received the two-dose vaccine.

When will the Moderna vaccine be available in the UK?

The new vaccine against coronavirus could arrive int he UK “as early as Spring 2021”, according to the government.

The government is in “advanced discussions with Moderna to ensure UK access to their vaccine as part of the wider UK portfolio”.

A government spokesperson added: “Moderna are currently scaling up their European supply chain which means these doses would become available in spring 2021 in the UK at the earliest.”

Moderna says it plans to apply for approval to use the vaccine in the next few weeks.

By the end of the year Moderna expects to have approximately 20 million doses ready to ship to the US.

The company remains on track to manufacture 500 million to 1billion doses globally by 2021.

The UK has already secured 40 million doses of a vaccine from Pfizer, which uses the same technology as Moderna.

Is the Moderna vaccine safe?

  • Four coronavirus lockdown options the government could implement for Christmas

Moderna has said that “no significant safety concerns” were reported, and that the vaccine was generally safe and well tolerated.

However, nothing, including paracetamol, is 100% safe.

Those who experienced side effect classed them as mild or moderate, including pain at the injection site and, after the second dose, fatigue, muscle pain and headaches.

However, Professor Peter Openshaw from Imperial College London, said: “These effects are what we would expect from a vaccine that is working and inducing a good immune response.”

Source: Read Full Article